Follicle-stimulating hormone treatment for men with idiopathic oligoteratoasthenozoospermia before in vitro fertilization: the impact on sperm microstructure and fertilization potential
Z. Ben-rafael et al., Follicle-stimulating hormone treatment for men with idiopathic oligoteratoasthenozoospermia before in vitro fertilization: the impact on sperm microstructure and fertilization potential, FERT STERIL, 73(1), 2000, pp. 24-30
Objective: To assess the effect of FSH on sperm fertilization potential and
sperm intracellular structure in men with oligoteratoasthenozoospermia and
a proven low fertilization rate in IVF.
Design: Prospective, randomized, partial crossover study.
Setting: IVF Unit, Colds Campus, Rabin Medical Center, Petah Tikva, Israel.
Patient(s): Forty normogonadotropic, normogonadal men with oligoteratoasthe
nozoospermia and at least one previous IVF attempt in which fertilization f
ailed or the fertilization rate was <30%.
Intervention(s): The men were randomly assigned to treatment with daily inj
ections of 75 IU of FSH or 150 IU of FSH for at least 60 days before IVF tr
eatment. A control group of men underwent an IVF cycle without treatment an
d then were randomly assigned to join group 1A or 1B for an additional IVF
cycle with treatment.
Main Outcome Measure(s): LH, FSH, and testosterone levels during FSH treatm
ent, evaluation of ultra-morphologic changes in sperm by electron microscop
y, and comparison of fertilization rates in the control and study groups.
Result(s): After treatment with 75 IU or 150 IU of FSH, the mean fertilizat
ion rates were 19.7% and 20.5%, respectively, compared with a 5.8% fertiliz
ation rate in the study control cycles.
Conclusion(s): Prolonged treatment with FSH results in a significant increa
se in fertilization rates. This effect revised and accepted maybe related t
o improvements in subcellular components of the sperm. (C) 1999 by American
Society for Reproductive Medicine.